Ulisse Garbin Selected Research

Ulisse Garbin Research Topics

Disease

6	Atherosclerosis 01/2011 - 10/2002
5	Inflammation (Inflammations) 01/2018 - 01/2008
3	Stable Angina 01/2018 - 09/2005
3	Unstable Angina 01/2018 - 09/2005
3	Coronary Artery Disease (Coronary Atherosclerosis) 11/2015 - 03/2006
2	Ischemia 04/2020 - 09/2018
2	Obesity 11/2015 - 12/2009
1	Peripheral Arterial Disease 09/2018
1	Alcoholism (Alcohol Abuse) 10/2017
1	Pulmonary Edema 10/2017
1	Renal Insufficiency (Renal Failure) 10/2017
1	Seizures (Absence Seizure) 10/2017
1	Brain Edema (Cerebral Edema) 10/2017
1	Liver Failure 10/2017
1	Disseminated Intravascular Coagulation 10/2017
1	Cardiac Arrhythmias (Arrythmia) 10/2017
1	Rhabdomyolysis 10/2017
1	Myocardial Infarction 02/2017
1	Emphysema 01/2016
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2016
1	Diabetes Mellitus 11/2015
1	Liver Diseases (Liver Disease) 11/2015
1	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2015
1	Hypoxia (Hypoxemia) 11/2015
1	Thrombosis (Thrombus) 08/2014
1	Hypertension (High Blood Pressure) 01/2008
1	Vascular Remodeling 01/2008
1	Essential Hypertension 04/2007

Drug/Important Bio-Agent (IBA)

4	NF-kappa B (NF-kB)IBA 01/2018 - 09/2005
4	oxidized low density lipoproteinIBA 01/2018 - 09/2005
3	LDL Lipoproteins (beta Lipoproteins)IBA 01/2018 - 04/2004
3	AntioxidantsIBA 01/2016 - 01/2008
3	Proteins (Proteins, Gene)FDA Link 01/2016 - 01/2008
2	Phenobarbital (Luminal)FDA Link 02/2017 - 08/2014
2	oxidized- L- alpha- 1- palmitoyl- 2- arachidonoyl- sn- glycero- 3- phosphorylcholineIBA 01/2016 - 03/2014
2	Phospholipids (Phosphatides)FDA LinkGeneric 03/2014 - 01/2011
1	Ezetimibe (Zetia)FDA Link 04/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	InterleukinsIBA 01/2018
1	C-Reactive ProteinIBA 01/2018
1	Dacarbazine (DIC)FDA LinkGeneric 10/2017
1	SolutionsIBA 10/2017
1	Malondialdehyde (Propanedial)IBA 01/2016
1	Messenger RNA (mRNA)IBA 01/2016
1	Heme Oxygenase-1IBA 01/2016
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2016
1	1- palmitoyl- 2- arachidonyl- 3- phosphorylcholineIBA 03/2014
1	ElementsIBA 03/2014
1	Lipoproteins (Lipoprotein)IBA 01/2011
1	Class E Scavenger Receptors (Lectin Like Oxidized Low Density Lipoprotein Receptor 1)IBA 03/2009
1	Atenolol (Tenormin)FDA LinkGeneric 01/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2008
1	P-SelectinIBA 01/2008
1	E-SelectinIBA 01/2008
1	Thromboplastin (Tissue Factor)IBA 01/2008
1	Endothelin-1 (Endothelin 1)IBA 01/2008
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2008
1	Metalloproteases (Metalloproteinases)IBA 01/2008
1	Nebivolol FDA Link 01/2008
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2007
1	ApolipoproteinsIBA 04/2004
1	lacidipineIBA 04/2004
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2002